Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

This approval marks a breakthrough for individuals diagnosed with hormone receptor-positive (HR+)/HER2-negative stage II and ...

USFDA sought a detailed remediation plan from the drug firm with timelines to address the findings of the contamination ...

The USFDA's inspection of the facility took place from April 15 to 23, 2024, uncovering significant breaches of CGMP ...

Aurobindo Pharma shares fell following the news that the US Food and Drug Administration has issued the Establishment ...

The USFDA has issued a warning letter to Zydus Lifesciences for manufacturing lapses at its Jarod plant in Gujarat, citing contamination and inadequate investigations.

Strides Pharma Science's subsidiary receives USFDA approval for its generic version of antidepressant Fluoxetine tablets in ...

The US Food and Drug Administration (USFDA) has issued a warning letter to Zydus Lifesciences for significant violations of good manufacturing practices at their Gujarat facility. The letter points ...

In a warning letter to company's Managing Director Sharvil Patel, the US Food and Drug Administration (USFDA) noted that the drug maker failed to investigate contamination identified in drug ...